Management of Newly Diagnosed Symptomatic Multiple Myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines
Year: 2009
Type: article
Source: Mayo Clinic Proceedings
Authors: Shaji K. Kumar, Joseph R. Mikhael, Francis K. Buadi, David Dingli, Angela Dispenzieri, Rafael Fonseca, Morie A. Gertz, Philip R. Greipp, Suzanne R. Hayman, Robert A. Kyle, Martha Q. Lacy, John A. Lust, Craig B. Reeder, Vivek Roy, Stephen J. Russell, Kristen E. Detweiler Short, A. Keith Stewart, Thomas E. Witzig, Steven R. Zeldenrust, Robert J. Dalton, S. Vincent Rajkumar, P. Leif Bergsagel
Institutions: Mayo Clinic, Mayo Clinic in Arizona, Mayo Clinic in Florida
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Awards: G1234102995, G2018127191, G2047616348, G2269554244, G243382380, G3071120689, G3276378173, Angiogenesis and thalidomide therapy in multiple myeloma, G3470051022, G3710371131, G423126875, Mouse Model of Age-Associated Monoclonal Gammopathy, SPORE in Multiple Myeloma, G5611102133, G6317171496, G6466650199, G6880884320, G7403876421, G7585679282, Studies on Monoclonal Gammopathies, Comparative Pharmaco-oncogenomics of Myeloma Drug Resistance, Radiovirotherapy for Multiple Myeloma, G8687299782, Paul Calabresi Program in Clinical/Translational Research at Mayo Clinic, G918026202
OpenAlex ID: W2040925557